Mustang Bio, INC. (MBIO) — 8-K Filings

All 8-K filings from Mustang Bio, INC.. Browse 26 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (26)

Mustang Bio Files 8-K for Shareholder Vote & Other Events — Dec 23, 2025 Risk: medium
Mustang Bio, Inc. filed an 8-K on December 23, 2025, reporting events that occurred on December 17, 2025. The filing indicates that the company is submitting ma
Mustang Bio Files 8-K: Corporate Updates — Jul 9, 2025 Risk: low
Mustang Bio, Inc. filed an 8-K on July 9, 2025, reporting other events and financial statements as of July 7, 2025. The filing details the company's principal e
Mustang Bio Files 8-K: Corporate Updates — Mar 5, 2025 Risk: low
Mustang Bio, Inc. filed an 8-K on March 5, 2025, reporting other events and financial statements. The filing details the company's principal executive offices l
Mustang Bio Completes Asset Acquisition/Disposition — Feb 27, 2025 Risk: medium
Mustang Bio, Inc. reported on February 21, 2025, the completion of an acquisition or disposition of assets. The filing also includes other events and financial
Mustang Bio Files 8-K on Security Holder Vote Matters — Feb 21, 2025 Risk: medium
Mustang Bio, Inc. filed an 8-K on February 21, 2025, reporting an event that occurred on February 19, 2025. The filing indicates a submission of matters to a vo
Mustang Bio Terminates Material Definitive Agreement — Feb 13, 2025 Risk: medium
Mustang Bio, Inc. announced on February 7, 2025, the termination of a material definitive agreement. The company, incorporated in Delaware with its principal ex
Mustang Bio Enters Material Definitive Agreement — Feb 11, 2025 Risk: medium
Mustang Bio, Inc. announced on February 5, 2025, that it has entered into a material definitive agreement. The company, incorporated in Delaware with its princi
Mustang Bio Sells Subsidiary, Focuses on Gene Therapy — Jan 17, 2025 Risk: medium
Mustang Bio, Inc. announced on January 14, 2025, that it has entered into a definitive agreement to sell its wholly-owned subsidiary, Mustang Bio Development, L
Mustang Bio Files 8-K on Shareholder Vote Matters — Jan 10, 2025 Risk: low
Mustang Bio, Inc. filed an 8-K on January 10, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain details about
Mustang Bio Files 8-K on Shareholder Vote Matters — Jan 2, 2025 Risk: low
Mustang Bio, Inc. filed an 8-K on January 2, 2025, reporting on matters submitted to a vote of security holders as of December 26, 2024. The filing details the
Mustang Bio Faces Nasdaq Delisting Warning — Nov 15, 2024 Risk: high
Mustang Bio, Inc. announced on November 12, 2024, that it received a notice from the Nasdaq Stock Market indicating non-compliance with listing rules. The compa
Mustang Bio Files 8-K on Shareholder Nominations — Nov 6, 2024 Risk: medium
Mustang Bio, Inc. filed an 8-K on November 6, 2024, to report on shareholder nominations pursuant to Exchange Act Rule 14a-11 and other events. The filing does
Mustang Bio Announces CMO Departure, Equity Sales — Oct 25, 2024 Risk: medium
Mustang Bio, Inc. announced on October 23, 2024, the departure of its Chief Medical Officer, Dr. Manuel Litchman. The company also reported on unregistered sale
Mustang Bio Faces Delisting Concerns — Sep 13, 2024 Risk: high
Mustang Bio, Inc. filed an 8-K on September 13, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing ind
Mustang Bio Terminates Agreement, Completes Asset Deal — Jul 3, 2024 Risk: medium
Mustang Bio, Inc. announced on June 27, 2024, the termination of a material definitive agreement and the completion of an acquisition or disposition of assets.
Mustang Bio Enters Material Agreement, Reports Equity Sales — Jun 24, 2024 Risk: medium
Mustang Bio, Inc. announced on June 19, 2024, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity se
Mustang Bio Terminates Material Agreement — Jun 6, 2024 Risk: medium
Mustang Bio, Inc. announced on May 31, 2024, the termination of a material definitive agreement. The company also filed its financial statements and exhibits as
Mustang Bio Faces Nasdaq Delisting Warning — May 21, 2024 Risk: high
Mustang Bio, Inc. announced on May 16, 2024, that it received a deficiency letter from the Nasdaq Stock Market indicating it is not in compliance with the minim
Mustang Bio Files 8-K for Material Agreement — May 2, 2024 Risk: medium
Mustang Bio, Inc. filed an 8-K on April 29, 2024, reporting the entry into a material definitive agreement and other events. The filing also includes financial
Mustang Bio Reports Exit/Disposal Costs — Apr 12, 2024 Risk: medium
Mustang Bio, Inc. filed an 8-K on April 12, 2024, reporting costs associated with exit or disposal activities as of April 10, 2024. The filing does not specify
Mustang Bio Sells Subsidiary, Exits Operations — Mar 29, 2024 Risk: high
Mustang Bio, Inc. announced on March 28, 2024, that it has entered into a definitive agreement to sell its wholly-owned subsidiary, Mustang Bio Holdings, Inc.,
Mustang Bio Faces Nasdaq Delisting Warning — Mar 15, 2024 Risk: high
Mustang Bio, Inc. announced on March 13, 2024, that it received a notification from The Nasdaq Stock Market indicating a failure to meet the minimum bid price r
Mustang Bio Files 8-K for Operations and Financials — Mar 11, 2024 Risk: low
Mustang Bio, Inc. filed an 8-K on March 11, 2024, to report on its results of operations and financial condition, as well as to file financial statements and ex
Mustang Bio Files 8-K for Undisclosed 'Other Event' — Feb 14, 2024 Risk: medium
Mustang Bio, Inc. filed an 8-K Current Report with the SEC on February 14, 2024, reporting an "Other Event" that occurred on February 12, 2024. The filing indic
Mustang Bio Reports Officer/Director Changes, Comp Arrangements — Jan 25, 2024
Mustang Bio, Inc. filed an 8-K on January 25, 2024, reporting an event that occurred on January 19, 2024. The filing indicates changes related to the departure
Mustang Bio Files Routine 8-K, No New Material Info — Jan 4, 2024
Mustang Bio, Inc. filed an 8-K on January 4, 2024, reporting an "Other Event" that occurred on December 28, 2023. This filing simply confirms the company's basi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX